Our goal is to progress the clinical development of our discoveries,
substantially increase their values, and to ultimately market or out-license.
The patent in progress at MetiMedi Pharmaceutical is as follows.
OMT-110 Main patent
Formulation patent
Chronic inflammatory diseases patent
